Hapten immunology and allergic reactions in humans.
D000818:Animals; D001327:Autoimmune Diseases / Q000139:chemically induced; D002352:Carrier Proteins / Q000276:immunology; D004342:Drug Hypersensitivity / Q000235:genetics / Q000276:immunology*; D004782:Environmental Health; D006680:HLA Antigens / Q000235:genetics; D006241:Haptens / Q000276:immunology*; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D007116:Immunization, Passive; D007538:Isoniazid / Q000009:adverse effects; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D046911:Macromolecular Substances; D008750:Methyldopa / Q000009:adverse effects; D009578:Nitrobenzenes / Q000627:therapeutic use; D009696:Nucleic Acids / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects
D002352:Carrier Proteins; D006680:HLA Antigens; D006241:Haptens; D046911:Macromolecular Substances; D009578:Nitrobenzenes; D009696:Nucleic Acids; D010406:Penicillins; D006830:Hydralazine; D008750:Methyldopa; D011342:Procainamide; D007538:Isoniazid